, Fiche des taches des différents intervenants dans l'étude CKD-REIN : Sites cliniques et investigateurs de l'étude CKD-REIN, par région Alsace : Prs T. Hannedouche et B. Moulin

C. Aquitaine-:-pr, (. Combe, . Chu, ). Bordeaux, J. P. Dr et al., Clinique St Augustin

F. Ile-de,

(. Belenfant, . Ch, ). Montreuil, and P. E. Thervet, Dr P. Urena (Clinique du Landy, St Ouen), Dr M. Delahousse (Hôpital

. Languedoc-roussillon,

, Epinal

M. Dr, D. B. Jamali, and . Hacq, Essey-les-Nancy), Dr V. Panescu, Dr M. Bellou

. Midi-pyrénées,

. Nord-pas-de-calais, Dr R. Azar (CH, Dunkerque), Dr M. Hoffmann (Hôpital privé

. Pays-de-la-loire, Pr M. Hourmant

, Dr E. Magnant (Polyclinique du

. Rhône-alpes,

, Les investigateurs, cités ci-dessus

. Les-attachés-de-recherche and . Cliniques, ARCs) de chaque site investigateur ont effectué les interviews des patients, et ont reportés les données issues des questionnaires, interviews, visite de routine

V. S. Stel, International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue, Nephrol. Dial. Transplant, vol.32, pp.129-135, 2017.

, National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification, Am. J. Kidney Dis, vol.39, pp.1-266, 2002.

, Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group

, Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Inter, 2013.

H. Autorité-de-santé, Guide du Parcours de Soins-Maladie Rénale Chronique de l'adulte, 2012.

B. Stengel, Cohorte française Chronic Kidney Disease-Réseau Épidémiologie et Information en Néphrologie (CKD-REIN) : mieux connaître la maladie rénale chronique, Néphrologie Thérapeutique, vol.12, pp.49-56, 2016.
DOI : 10.1016/j.nephro.2016.01.005

D. W. Cockcroft and M. H. Gault, Prediction of creatinine clearance from serum creatinine, Nephron, vol.16, pp.31-41, 1976.

A. S. Levey, A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, Ann. Intern. Med, vol.130, p.461, 1999.

A. S. Levey, A New Equation to Estimate Glomerular Filtration Rate, Ann. Intern. Med, vol.150, pp.604-612, 2009.

M. Froissart, J. Rossert, C. Jacquot, M. Paillard, and P. Houillier, Predictive Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Estimating Renal Function, J. Am. Soc. Nephrol, vol.16, pp.763-773, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00149221

A. S. Levey and J. Coresh, Chronic kidney disease, The Lancet, vol.379, pp.165-180, 2012.

R. A. Nugent, S. F. Fathima, A. B. Feigl, and D. Chyung, The Burden of Chronic Kidney Disease on Developing Nations: A 21st Century Challenge in Global Health, Nephron Clin. Pract, vol.118, pp.269-277, 2011.

A. C. Webster, E. V. Nagler, R. L. Morton, and P. Masson, Chronic Kidney Disease. The Lancet, vol.389, pp.1238-1252, 2017.

B. Stengel, L'insuffisance rénale chronique : une épidémie ?, Presse Médicale, vol.40, pp.1020-1027, 2011.

A. M. El-nahas and A. K. Bello, Chronic kidney disease: the global challenge, The Lancet, vol.365, pp.331-340, 2005.

K. T. Mills, A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010, Kidney Int, vol.88, pp.950-957, 2015.

C. Couchoud, The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France, Nephrol. Dial. Transplant, vol.21, pp.411-418, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00452918

C. N. Agence-de-la-biomédecine, , 2014.

F. Locatelli, Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrol. Dial. Transplant, vol.19, pp.121-132, 2004.

S. M. Moe, T. Drüeke, N. Lameire, and G. Eknoyan, Chronic Kidney DiseaseMineral-Bone Disorder: A New Paradigm, Adv. Chronic Kidney Dis, vol.14, pp.3-12, 2007.

E. V. Nagler, European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines, Nephrol. Dial. Transplant, vol.29, pp.731-738, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01858993

L. A. Inker, J. Coresh, A. S. Levey, M. Tonelli, and P. Muntner, Estimated GFR, Albuminuria, and Complications of Chronic Kidney Disease, J. Am. Soc. Nephrol, vol.22, pp.2322-2331, 2011.

A. Seidowsky, Z. A. Massy, M. Metzger, and B. Stengel, Hypertension résistante et maladie rénale chronique : épidémiologie et pronostic, Néphrologie Thérapeutique, vol.10, pp.137-144, 2014.

D. Herpin, Hypertension artérielle résistante : une définition et une prise en charge qui évoluent, Arch. Mal. Coeur Vaiss.-Prat, p.13, 2016.

J. W. Koo, Renal Interstitial Fibrosis and Angiotensin Inhibition, Electrolytes Blood Press. E BP, vol.4, pp.35-43, 2006.

G. Weiss and L. T. Goodnough, Anemia of Chronic Disease. N. Engl. J. Med, vol.352, pp.1011-1023, 2005.

J. L. Babitt and H. Y. Lin, Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD, Am. J. Kidney Dis. Off. J. Natl. Kidney Found, vol.55, pp.726-741, 2010.

S. R. Gandra, Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review, Am. J. Kidney Dis, vol.55, pp.519-534, 2010.

A. Phrommintikul, S. J. Haas, M. Elsik, and H. Krum, Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis, The Lancet, vol.369, pp.381-388, 2007.

G. F. Strippoli, G. Tognoni, S. D. Navaneethan, A. Nicolucci, and J. C. Craig, Haemoglobin targets: we were wrong, time to move on, The Lancet, vol.369, pp.346-350, 2007.

S. Moe, Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, vol.69, pp.1945-1953, 2006.

, Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD), KDIGO 2017 Clinical, vol.7, pp.1-59, 2017.

W. G. Goodman, Coronary-Artery Calcification in Young Adults with

, Stage Renal Disease Who Are Undergoing Dialysis, N. Engl. J. Med, vol.342, pp.1478-1483, 2000.

A. P. Guérin, G. M. London, S. J. Marchais, and F. Metivier, Arterial stiffening and vascular calcifications in end-stage renal disease, Nephrol. Dial. Transplant, vol.15, pp.1014-1021, 2000.

D. E. Weiner, Uric Acid and Incident Kidney Disease in the Community, J. Am. Soc. Nephrol, vol.19, pp.1204-1211, 2008.

K. M. Talaat and A. R. El-sheikh, The Effect of Mild Hyperuricemia on Urinary Transforming Growth Factor Beta and the Progression of Chronic Kidney Disease, Am. J. Nephrol, vol.27, pp.435-440, 2007.

M. A. Limdi, M. R. Crowley, T. M. Beasley, N. A. Limdi, and M. Allon, Influence of kidney function on risk of hemorrhage among patients taking warfarin : a cohort study, Am. J. Kidney Dis. Off. J. Natl. Kidney Found, vol.61, pp.354-357, 2013.

J. Jansen, J. Jankowski, P. R. Gajjala, J. F. Wetzels, and R. Masereeuw, Disposition and clinical implications of protein-bound uremic toxins, Clin. Sci, vol.131, pp.1631-1647, 2017.

A. Bénard-laribière, Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study, Fundam. Clin. Pharmacol, vol.29, pp.106-111, 2015.

M. Pierson-marchandise, The drugs that mostly frequently induce acute kidney injury: a case ? noncase study of a pharmacovigilance database, Br. J. Clin. Pharmacol, vol.83, pp.1341-1349, 2017.

S. S. Taber and D. A. Pasko, The epidemiology of drug-induced disorders: the kidney, Expert Opin. Drug Saf, vol.7, pp.679-690, 2008.

F. Chang, A. O'hare, Y. Miao, and M. A. Steinman, Use of renally inappropriate medications in older veterans: A national study, J. Am. Geriatr. Soc, vol.63, pp.2290-2297, 2015.

J. T. Hanlon, Potentially Inappropriate Prescribing of Primarily Renally Cleared Medications for Older Veterans Affairs Nursing Home Patients, J. Am. Med. Dir. Assoc, vol.12, pp.377-383, 2011.

G. Breton, Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function-the Three-City population-based study, Nephrol. Dial. Transplant, vol.26, pp.2852-2859, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00850199

L. Becquemont, Cardiovascular Drugs and Metformin Drug Dosage According to Renal Function in Non-Institutionalized Elderly Patients, Basic Clin. Pharmacol. Toxicol, vol.118, pp.468-473, 2016.

A. D. Falconnier, W. E. Haefeli, R. A. Schoenenberger, C. Surber, and M. Martinfacklam, Drug Dosage in Patients with Renal Failure Optimized by Immediate Concurrent Feedback, J. Gen. Intern. Med, vol.16, pp.369-375, 2001.

Y. Hassan, R. J. Al-ramahi, N. A. Aziz, and R. Ghazali, Impact of a Renal Drug Dosing Service on Dose Adjustment in Hospitalized Patients with Chronic Kidney Disease, Ann. Pharmacother, vol.43, pp.1598-1605, 2009.

B. Stengel, The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study, Nephrol. Dial. Transplant, vol.29, pp.1500-1507, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00932387

G. R. Matzke, Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, vol.80, pp.1122-1137, 2011.

W. M. Michels, Performance of the Cockcroft-Gault, MDRD, and New CKDEPI Formulas in Relation to GFR, Age, and Body Size, Clin. J. Am. Soc. Nephrol, vol.5, pp.1003-1009, 2010.

L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey, Assessing Kidney FunctionMeasured and Estimated Glomerular Filtration Rate, N. Engl. J. Med, vol.354, pp.2473-2483, 2006.

D. D. Bois and E. F. Bois, Clinical calorimetry : tenth paper a formula to estimate the approximate surface aerea if height and weight be known, Arch. Intern. Med. XVII, pp.863-871, 1916.

H. Getachew, Y. Tadesse, and W. Shibeshi, Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, BMC Nephrol, vol.16, p.158, 2015.

W. H. Tesfaye, R. L. Castelino, B. C. Wimmer, and S. T. Zaidi, Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions, Int. J. Clin. Pract, vol.71, 2017.

A. Anabtawi and J. M. Miles, Metformin: nonglycemic effects and potential novel indications, Endocr. Pract, vol.22, pp.999-1007, 2016.

H. J. Whittington, Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon. Cardiovasc. Drugs Ther, vol.27, pp.5-16, 2013.

R. Roussel, Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis, Arch. Intern. Med, vol.170, pp.1892-1899, 2010.

S. Hung, Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study, Lancet Diabetes Endocrinol, vol.3, pp.605-614, 2015.

F. Kajbaf, P. Arnouts, M. De-broe, and J. Lalau, Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world, Pharmacoepidemiol. Drug Saf, vol.22, pp.1027-1035, 2013.

K. J. Lipska, C. J. Bailey, and S. E. Inzucchi, Use of Metformin in the Setting of Mildto-Moderate Renal Insufficiency, Diabetes Care, vol.34, pp.1431-1437, 2011.

R. Rachmani, Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications, Eur. J. Intern. Med, vol.13, pp.428-433, 2002.

H. J. Nye, W. G. Herrington, and . Metformin, The Safest Hypoglycaemic Agent in Chronic Kidney Disease?, Nephron Clin. Pract, vol.118, pp.380-383, 2011.

C. Muller, Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?, J. Diabetes Complications, vol.30, pp.675-680, 2016.

P. Muntner, Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study, Am. J. Kidney Dis, vol.55, pp.441-451, 2010.

Y. Mok, Serum uric acid and chronic kidney disease: the Severance cohort study, Nephrol. Dial. Transplant, vol.27, pp.1831-1835, 2012.

C. P. Wen, Is High Serum Uric Acid a Risk Marker or a Target for Treatment? Examination of its Independent Effect in a Large Cohort With Low Cardiovascular Risk, Am. J. Kidney Dis, vol.56, pp.273-288, 2010.

M. Goicoechea, Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk, Clin. J. Am. Soc. Nephrol, vol.5, pp.1388-1393, 2010.

K. R. Hande, R. M. Noone, and W. J. Stone, Severe allopurinol toxicity, Am. J. Med, vol.76, pp.47-56, 1984.

E. Cartet-farnier, L. Goutelle-audibert, P. Maire, B. De-la-gastine, and S. Goutelle, Implications of using the MDRD or CKD-EPI equation instead of the Cockcroft-Gault equation for estimating renal function and drug dosage adjustment in elderly patients, Fundam. Clin. Pharmacol, vol.31, pp.110-119, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02049666

D. M. Zulman, Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled Trials, J. Gen. Intern. Med, vol.26, pp.783-790, 2011.

A. Khanal, G. M. Peterson, R. L. Castelino, and M. D. Jose, Potentially Inappropriate Prescribing of Renally Cleared Drugs in Elderly Patients in Community and Aged Care Settings, Drugs Aging, vol.32, pp.391-400, 2015.

H. K. Doody, G. M. Peterson, D. Watson, and R. L. Castelino, Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment, Curr. Med. Res. Opin, vol.31, pp.525-535, 2015.

A. Papaioannou, J. Clarke, G. Campbell, and M. Bédard, Assessment of Adherence to Renal Dosing Guidelines in Long-Term Care Facilities, J. Am. Geriatr. Soc, vol.48, pp.1470-1473, 2000.